CD8A and neoplasm: This was further expanded on in the setting of ICIs with the discovery that radiated tumors cells release tumor-associated antigens that can further activate CD8+ T-cells by a variety of mechanisms including increasing the antigen-presenting dendritic cell presentation of T-cell receptors [TCR], thereby augmenting the adaptive immune response of CD8+ T-cells [59] (Figure 2).